You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MGCD516

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Liposarcoma, Metastatic Liposarcoma Trial in Boston, Saint Louis, New York (MGCD516)

Active, not recruiting
  • Liposarcoma
  • Metastatic Liposarcoma
  • MGCD516
  • Boston, Massachusetts
  • +2 more
Nov 23, 2022

Metastatic Cervical Cancer Trial (Tislelizumab, Sitravatinib)

Not yet recruiting
  • Metastatic Cervical Cancer
  • (no location specified)
Jan 31, 2023

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in Houston (other,

Completed
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Laboratory Biomarker Analysis
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 30, 2022

Healthy Adults Trial in Dallas (Sitravatinib 50 mg, Sitravatinib 100 mg, Itraconazole)

Recruiting
  • Healthy Adults
  • Sitravatinib 50 mg
  • +3 more
  • Dallas, Texas
    Labcorp Drug Development Clinical Research Unit
Feb 23, 2022

Healthy Adults Trial in Madison (Sitravatinib, Pantoprazole, Famotidine)

Completed
  • Healthy Adults
  • Madison, Wisconsin
    Covance Clinical Research Unit Inc.
Aug 24, 2022

Squamous Cell Carcinoma, Head And Neck, Squamous Cell Carcinoma Mouth, Squamous Cell Carcinoma of the Oral Cavity Trial in

Completed
  • Squamous Cell Carcinoma, Head And Neck
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Mar 30, 2021

Metastatic Breast Cancer Trial in Shanghai (Sitravatinib, Tislelizumab, Nab-paclitaxel)

Recruiting
  • Metastatic Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer
Jul 31, 2022

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +2 more
  • Nivolumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Clear-Cell Renal Cell Carcinoma Trial in Houston (Sitravatinib, Nivolumab, Ipilimumab)

Enrolling by invitation
  • Clear-Cell Renal Cell Carcinoma
  • Houston, Texas
    MD Anderson
Jan 23, 2022

Breast Cancer Stage IV, Triple Negative Breast Cancer, Breast Tumors Trial in Houston (Sitravatinib)

Recruiting
  • Breast Cancer Stage IV
  • +3 more
  • Houston, Texas
    Baylor College of Medicine
Jun 1, 2021

Advanced or Metastatic Solid Malignancies Trial in United States (Sitravatinib, Nivolumab, Pembrolizumab)

Enrolling by invitation
  • Advanced or Metastatic Solid Malignancies
  • Beverly Hills, California
  • +12 more
Aug 23, 2022

Advanced Biliary Tract Cancer Trial in Seoul (Sitravatinib, Tislelizumab)

Unknown status
  • Advanced Biliary Tract Cancer
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jan 23, 2021

NSCLC, Carcinoma, Squamous Cell, Adenocarcinoma Trial in United Kingdom (AZD4547, Vistusertib, Palbociclib)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Aberdeen, United Kingdom
  • +24 more
Nov 2, 2021

Advanced Cancer Trial in Korea, Republic of, United States (MGCD516)

Unknown status
  • Advanced Cancer
  • MGCD516
  • Birmingham, Alabama
  • +42 more
Jan 28, 2020

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Urothelial Carcinoma Ureter Trial in United States (Sitravatinib, Nivolumab,

Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Tucson, Arizona
  • +33 more
May 21, 2021

Clear Cell Renal Cell Carcinoma Trial in Houston (Sitravatinib, Nivolumab)

Active, not recruiting
Has Results
  • Clear Cell Renal Cell Carcinoma
  • Houston, Texas
    MD Anderson Cancer Center
Apr 27, 2021